Inflammation and autism

A study comparing postmortem brain tissue from 8 Caucasian children with Autism Spectrum Disorder (ASD) with 8 Caucasian children without ASD, ages 3-14 years, found that brains of children with ASD showed increased expression of the proinflammatory cytokine IL-18 and the antiinflammatory cytokine IL-37, which inhibited microglia-driven brain inflammation; the results suggest that IL-37 may represent a potential therapeutic candidate for ASD.

###

Article #19-06817: “IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin,” by Irene Tsilioni et al.

MEDIA CONTACT: Theoharis C. Theoharides, Tufts University, MA; tel: 617-217-8408, 617-636-6866; email:

[email protected]